Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why I rate DERM stock a Buy.
Zacks.com on MSN1d
SYK Stock Down Despite Q4 Earnings Beat and Spine Biz Divestment PlansStryker Corporation SYK reported fourth-quarter 2024 adjusted earnings per share (EPS) of $4.01, which beat the Zacks ...
A jump in fourth-quarter orders at truckmaker Volvo boosted hopes on Wednesday for a less bleak 2025, sending its shares up ...
DeepSeek has complicated the dominant narrative that's propped up the market for the last 2 years, challenging lofty ...
Austal's stock surge was driven by significant contracts and positive guidance for FY25. Click here to read why I maintain a ...
When you think of the next big electric vehicle (EV) stock, you might think of those vying to be the next Tesla, such as ...
Gov. Kevin Stitt has issued an executive order that will allow Oklahoma’s colleges and universities to facilitate direct payments to student-athletes for the use of their name, image and ...
Here are five key steps in the online stock trade lifecycle: Let's say you use an online account or a mobile app to buy 25 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback